메뉴 건너뛰기




Volumn 152, Issue 2, 2000, Pages 489-496

Efficacy and safety of atorvastatin in hyperlipidemic, type 2 diabetic patients. A 34-week, multicenter, open-label study

Author keywords

Atorvastatin; Hypercholesterolemia; Low density lipoprotein cholesterol; Triglyceride; Type 2 diabetes mellitus

Indexed keywords

ATORVASTATIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

EID: 17144457592     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00502-X     Document Type: Article
Times cited : (26)

References (32)
  • 1
    • 0027434291 scopus 로고
    • Effects of gemfibrozil on triglyceride levels in patients with NIDDM
    • Vinik A.I., Colwell J.A. Effects of gemfibrozil on triglyceride levels in patients with NIDDM. Diab. Care. 16:(1):1993;37-44.
    • (1993) Diab. Care , vol.16 , Issue.1 , pp. 37-44
    • Vinik, A.I.1    Colwell, J.A.2
  • 3
    • 0343532337 scopus 로고    scopus 로고
    • Clinical Practice Recommendations 1998
    • American Diabetes Association
    • American Diabetes Association. Clinical Practice Recommendations 1998. Diabetes Care 1998;21 (Suppl 1) 179-182.
    • (1998) Diabetes Care , vol.21 , Issue.SUPPL. 1 , pp. 179-182
  • 4
    • 0027192174 scopus 로고
    • Detection and management of lipid disorders in diabetes
    • Consensus Statement
    • Consensus Statement. Detection and management of lipid disorders in diabetes. Diab. Care 1993;16 (2):106-112.
    • (1993) Diab. Care , vol.16 , Issue.2 , pp. 106-112
  • 7
    • 1842326783 scopus 로고    scopus 로고
    • Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)
    • Pyorala K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diab Care 1997;20(4):614-620.
    • (1997) Diab Care , vol.20 , Issue.4 , pp. 614-620
    • Pyorala, K.1    Pedersen, T.R.2    Kjekshus, J.3    Faergeman, O.4    Olsson, A.G.5    Thorgeirsson, G.6
  • 8
    • 0342981862 scopus 로고    scopus 로고
    • Braunwald E for the cholesterol and recurrent events trial investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
    • Sacks F.M., Pfeffer M.A., Moye L.A., Rouleau J.L., Rutherford J.D., Cole T.G., Brown L., Warnica J.W., Arnold J.M., Wun C.C., Davis B.R. Braunwald E for the cholesterol and recurrent events trial investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. New Engl. J. Med. 335:1996;1001-1009.
    • (1996) New Engl. J. Med. , vol.335 , pp. 1001-1009
    • Sacks, F.M.1    Pfeffer, M.A.2    Moye, L.A.3    Rouleau, J.L.4    Rutherford, J.D.5    Cole, T.G.6    Brown, L.7    Warnica, J.W.8    Arnold, J.M.9    Wun, C.C.10    Davis, B.R.11
  • 9
    • 0032560807 scopus 로고    scopus 로고
    • Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
    • Haffner S.M., Lehto S., Ronnemaa T., Pyorala K., Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. New Engl. J. Med. 339:1998;229-234.
    • (1998) New Engl. J. Med. , vol.339 , pp. 229-234
    • Haffner, S.M.1    Lehto, S.2    Ronnemaa, T.3    Pyorala, K.4    Laakso, M.5
  • 10
    • 0001434733 scopus 로고
    • Expert Panel: Summary of the second report of the NCEP expert panel on detection, evaluation and treatment of high blood cholesterol (Adult treatment panel II)
    • National Cholesterol Education Program (NCEP)
    • National Cholesterol Education Program (NCEP) Expert Panel: Summary of the second report of the NCEP expert panel on detection, evaluation and treatment of high blood cholesterol (Adult treatment panel II). J Am Med Assoc 1993;209:3015-3023.
    • (1993) J Am Med Assoc , vol.209 , pp. 3015-3023
  • 11
    • 0031975337 scopus 로고    scopus 로고
    • Management of dyslipidemia in adults with diabetes
    • American Diabetes Association
    • American Diabetes Association. Management of dyslipidemia in adults with diabetes. Diab. Care 1998;21:179-182.
    • (1998) Diab. Care , vol.21 , pp. 179-182
  • 12
    • 0032515775 scopus 로고    scopus 로고
    • Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23)
    • Turner R.C., Millns H., Neil H.A., Stratton I.M., Manley S.E., Matthews D.R., Holman R.R. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23). Br. Med. J. 316:1998;823-828.
    • (1998) Br. Med. J. , vol.316 , pp. 823-828
    • Turner, R.C.1    Millns, H.2    Neil, H.A.3    Stratton, I.M.4    Manley, S.E.5    Matthews, D.R.6    Holman, R.R.7
  • 14
    • 0010420182 scopus 로고    scopus 로고
    • Effectiveness of atorvastatin in treating patients to LDL-C goals compared with lovastatin, pravastatin and simvastatin
    • Nawrocki J., Shurzinske L., Black D.M. Effectiveness of atorvastatin in treating patients to LDL-C goals compared with lovastatin, pravastatin and simvastatin. Atherosclerosis. 134:1997;120.
    • (1997) Atherosclerosis , vol.134 , pp. 120
    • Nawrocki, J.1    Shurzinske, L.2    Black, D.M.3
  • 18
    • 0000677439 scopus 로고
    • Estimation of the concentration of low density lipoproteins cholesterol in plasma without the use of the ultracentrifuge
    • Friedewald W.T., Levy I.R., Fredrickson D.S. Estimation of the concentration of low density lipoproteins cholesterol in plasma without the use of the ultracentrifuge. Clin. Chem. 18:1972;449-502.
    • (1972) Clin. Chem. , vol.18 , pp. 449-502
    • Friedewald, W.T.1    Levy, I.R.2    Fredrickson, D.S.3
  • 19
    • 0002943799 scopus 로고
    • Lipid and lipoprotein analysis
    • Washington DC: US Department of Health, Education and Welfare publication NIH 75-628
    • Lipid and lipoprotein analysis. In: Manual of laboratory Operations: Lipid Research Clinics Program Report. Washington DC: 1974. US Department of Health, Education and Welfare publication NIH 75-628, Vol 1.
    • (1974) In: Manual of Laboratory Operations: Lipid Research Clinics Program Report , vol.1
  • 20
    • 0032032592 scopus 로고
    • Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)
    • Jones P., Kafonek S., Laurora I., Hunninghake D. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study). Am. J. Cardiol. 81:1988;582-587.
    • (1988) Am. J. Cardiol. , vol.81 , pp. 582-587
    • Jones, P.1    Kafonek, S.2    Laurora, I.3    Hunninghake, D.4
  • 22
    • 4243407053 scopus 로고    scopus 로고
    • Efficacy and safety of atorvastatin in hyperlipidemic patients with concurrent hypertension or non-insulin-dependent diabetes mellitus
    • 7-11 June Amsterdam
    • Black DM, Bakker-Arkema R, Heinonen T, Nawrocki JW. Efficacy and safety of atorvastatin in hyperlipidemic patients with concurrent hypertension or non-insulin-dependent diabetes mellitus. Presented at the International Society of Hypertension, 7-11 June 1998, Amsterdam.
    • (1998) Presented at the International Society of Hypertension
    • Black, D.M.1    Bakker-Arkema, R.2    Heinonen, T.3    Nawrocki, J.W.4
  • 23
    • 0030967489 scopus 로고    scopus 로고
    • Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia. Atorvastatin Study Group I
    • Davidson M., McKenney J., Stein E., Schrott H., Bakker-Arkema R., Fayyad R., Black D. Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia. Atorvastatin Study Group I. Am. J. Cardiol. 79:(11):1997;1475-1481.
    • (1997) Am. J. Cardiol. , vol.79 , Issue.11 , pp. 1475-1481
    • Davidson, M.1    McKenney, J.2    Stein, E.3    Schrott, H.4    Bakker-Arkema, R.5    Fayyad, R.6    Black, D.7
  • 26
    • 0032568086 scopus 로고    scopus 로고
    • Role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) in familial combined hypercholesterolemia
    • Schonfeld G., Aguilar-Salinas C.A., Nizar E. Role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) in familial combined hypercholesterolemia. Am. J. Cardiol. 81:(4A):1998;43B-46B.
    • (1998) Am. J. Cardiol. , vol.81 , Issue.4 A
    • Schonfeld, G.1    Aguilar-Salinas, C.A.2    Nizar, E.3
  • 27
    • 0002013221 scopus 로고    scopus 로고
    • Effect of atorvastatin on serum levels of lipoproteins in French Canadians with homozygous or compound heterozygous familial hypercholesterolemia
    • Couture P., Gaudet D., Brun D., Bergeron J., Cantin L., Black O., Gagné C. Effect of atorvastatin on serum levels of lipoproteins in French Canadians with homozygous or compound heterozygous familial hypercholesterolemia. Atherosclerosis. 134:1997;54-59.
    • (1997) Atherosclerosis , vol.134 , pp. 54-59
    • Couture, P.1    Gaudet, D.2    Brun, D.3    Bergeron, J.4    Cantin, L.5    Black, O.6    Gagné, C.7
  • 28
    • 0030716524 scopus 로고    scopus 로고
    • Decreased production of low density lipoprotein by atorvastatin after apheresis in homozygous familial hypercholesterolemia
    • Marais A.D., Naoumova R.P., Firth J.C., Penny C., Neuwirth C.K., Thompson G.R. Decreased production of low density lipoprotein by atorvastatin after apheresis in homozygous familial hypercholesterolemia. J. Lipid Res. 38:(10):1997;2071-2078.
    • (1997) J. Lipid Res. , vol.38 , Issue.10 , pp. 2071-2078
    • Marais, A.D.1    Naoumova, R.P.2    Firth, J.C.3    Penny, C.4    Neuwirth, C.K.5    Thompson, G.R.6
  • 29
    • 0343968223 scopus 로고    scopus 로고
    • Data on file. Parke-Davis Pharmaceutical Research Division. Warner-Lambert Company, Ann Arbor, Michigan
    • Data on file. Parke-Davis Pharmaceutical Research Division. Warner-Lambert Company, Ann Arbor, Michigan.
  • 31
    • 0029793477 scopus 로고    scopus 로고
    • Will correction of dyslipoproteinaemia reduce coronary heart disease risk in patients with non-insulin-dependent diabetes? Need for trial evidence
    • Pyorala K., Steiner G. Will correction of dyslipoproteinaemia reduce coronary heart disease risk in patients with non-insulin-dependent diabetes? Need for trial evidence. Ann. Med. 28:(4):1996;357-362.
    • (1996) Ann. Med. , vol.28 , Issue.4 , pp. 357-362
    • Pyorala, K.1    Steiner, G.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.